Schizophrenia
Breakthrough Study Links Rare Genetic Mutation to Schizophrenia, Reveals Impact on Brain Function
2025-02-24
CNS Drug-Maker Reviva Announces $18M Public Offering of Common Stock and Warrants to Fund R&D
2024-12-17
Neurocrine, Takeda Look to Build on Positives Post Luvadaxistat’s Schizophrenia Trial Failure
2021-03-03